Characterization of Skin Changes From the Use of Moisturizers in Participants With Cancer Experiencing Dermatological Adverse Events

Characterization of Skin Changes (Clinical, Physiological and Pathological) Leading to Dermatological Adverse Events From Chemotherapy, Targeted Therapy, Hormonal Therapy, and Immune Checkpoint Inhibitors

The goal of this clinical trial is to evaluate whether cosmeceutical topical moisturizers can help with skin dryness in participants with cancer experiencing a dermatological adverse event from cancer therapies. The main question it aims to answer is:

Does cosmeceutical topical moisturizers help with skin dryness?

Participants will:

• Visit the clinic for a baseline visit to complete skin evaluation and tests.
• Apply cosmeceutical topical moisturizers daily from baseline up until the follow-up visit.
• Visit the clinic for a follow-up visit (approximately 2-4 weeks from baseline) for a repeat skin evaluation and tests.

Inclusion Criteria:

• Adult patient (18 years or older).
• Patients diagnosed with cancer.
• Patient receiving cancer treatment or therapy (receiving chemotherapy, targeted treatment, hormonal therapy, and/or immune checkpoint inhibitors).
• Patient experiencing a dermatological adverse event from a cancer treatment or therapy.

Exclusion Criteria:

• Patient is unable to understand scope of the study.
• Patient is unable to provide written informed consent.
• Patient is healthy.